PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.

about

Association of the plasminogen activator inhibitor-1 (PAI-1) Gene -675 4G/5G and -844 A/G promoter polymorphism with risk of keloid in a Chinese Han population.Mice deficient in Sfrp1 exhibit increased adiposity, dysregulated glucose metabolism, and enhanced macrophage infiltration

P2860

Q34454228-D0139D44-9022-4170-B59C-334746F3A9B9 Q35067279-7BF99454-B2E4-48BF-9313-60BC7C6A4FA0

P2860

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.

Item

http://www.wikidata.org/entity/Q36386574

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@ast

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@en

type

Item

label

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@ast

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@en

prefLabel

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@ast

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@en

P1476

PAI-1 promoter 4G/5G polymorph ...... : Evidence from meta-analysis.

@en

P2093

Hong Chen

http://www.w3.org/2001/XMLSchema#string

Jian Wu

http://www.w3.org/2001/XMLSchema#string

Jie Qin

http://www.w3.org/2001/XMLSchema#string

Liping Xie

http://www.w3.org/2001/XMLSchema#string

Xianglai Xu

http://www.w3.org/2001/XMLSchema#string

Xiangyi Zheng

http://www.w3.org/2001/XMLSchema#string

Xin Xu

http://www.w3.org/2001/XMLSchema#string

Yanqi Xie

http://www.w3.org/2001/XMLSchema#string

Yeqing Mao

http://www.w3.org/2001/XMLSchema#string

Yi Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Meta-analysis in clinical trials

Statistical aspects of the analysis of data from retrospective studies of disease

Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.

Plasminogen-activator inhibitor type 1 and coronary artery disease.

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression

Cancer metastasis as a therapeutic target.

Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1.

P304

1127-1133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2012.734

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233889408

http://www.w3.org/2001/XMLSchema#string

P698

23226787

http://www.w3.org/2001/XMLSchema#string

P932

3494103

http://www.w3.org/2001/XMLSchema#string

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.

about

P2860

P2860

PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932